Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. SC 13D Stake Beneficial Ownership Report
  2. 425 Deal Prospectus/Communication re Business Combination
  3. UPLOAD Other SEC-generated Letter
  4. CT ORDER Other Confidential Order
  5. 4 Insider Changes in Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. 425 Deal Prospectus/Communication re Business Combination
  8. 8-K Event Material agreement · Regulation FD disclosure
  9. 425 Deal Prospectus/Communication re Business Combination
  10. 8-K Event Material agreement · Agreement ended · Debt accelerated · Regulation FD disclosure
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. 8-K Event Material agreement
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. UPLOAD Other SEC-generated Letter
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. CT ORDER Other Confidential Order
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 79 of 115 · 2,300 filings